Jeroen Jansen, PhD

Title(s)Associate Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address490 Illinois Street
San Francisco CA 94158
ORCID ORCID Icon0000-0003-2686-9217 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Erasmus University, Rotterdam, NetherlandsPhD12/2004Epidemiology

    Collapse Overview 
    Collapse Overview
    Jeroen is a methodologist working at the intersection of evidence synthesis, biostatistics, and health economics. He is a core faculty member with the UCSF Center for Translational and Policy Research on Precision Medicine (TRANSPERS), located in the Department of Clinical Pharmacy.

    Jeroen has worked on research to understand the clinical and economic value of healthcare interventions. His research has frequently been conducted in the context of health technology assessment (HTA), with a focus on comparative effectiveness and cost-effectiveness. Prompted by the challenges encountered in applied research projects, Jeroen has performed methodological research. Notable contributions are the development of novel statistical methods to overcome the typical challenges in model-based cost-effectiveness evaluations characterized by gaps in the evidence base and complex evidence structures. Furthermore, Jeroen led initiatives to develop guidance for consumers and producers of network meta-analysis studies. He has promoted a more transparent and credible approach to model-based health economic evaluations and led the development of open-source simulation models to illustrate its feasibility. Jeroen has been involved in the ongoing development of an R software package to develop simulation models for health economic evaluations.

    Jeroen’s current research interests are the clinical and economic value of precision medicine, incorporating health disparities in health economic modeling studies, and statistical methods for evidence synthesis.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma. Value Health. 2022 Dec 09. Cope S, Chan K, Campbell H, Chen J, Borrill J, May JR, Malcolm W, Branchoux S, Kupas K, Jansen JP. PMID: 36503035.
      View in: PubMed   Mentions:    Fields:    
    2. Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma. Leuk Lymphoma. 2022 Dec; 63(13):3052-3062. Oluwole OO, Chen JMH, Chan K, Patel AR, Jansen JP, Keeping S, Zheng Y, Snider JT, Locke FL. PMID: 36048026.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Network Meta-analysis on Disconnected Evidence Networks When Only Aggregate Data Are Available: Modified Methods to Include Disconnected Trials and Single-Arm Studies while Minimizing Bias. Med Decis Making. 2022 10; 42(7):906-922. Thom H, Leahy J, Jansen JP. PMID: 35531938; PMCID: PMC9459361.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Assessments of the Value of New Interventions Should Include Health Equity Impact. Pharmacoeconomics. 2022 05; 40(5):489-495. Jansen JP, Trikalinos TA, Phillips KA. PMID: 35237944; PMCID: PMC8890816.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials. BMC Med. 2021 12 06; 19(1):307. Hong YD, Jansen JP, Guerino J, Berger ML, Crown W, Goettsch WG, Mullins CD, Willke RJ, Orsini LS. PMID: 34865623; PMCID: PMC8647453.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor?+?dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma. Leuk Lymphoma. 2021 10; 62(10):2482-2491. Rodriguez-Otero P, Ayers D, Cope S, Davies FE, Delforge M, Mojebi A, Jansen JP, Weisel K, Hege K, Dhanasiri S. PMID: 33896344.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis. Clinical Kidney Journal. 2021; 4(14):1136-46. Ortiz A, Kanters S, Hamed A, DasMahapatra P, Poggio E, Maski M, Aguiar M, Ponce E, Jansen JP, Ayers D, Goldgrub R.
    8. Complicated legacies: The human genome at 20. Science. 2021 02 05; 371(6529):564-569. Jones KM, Cook-Deegan R, Rotimi CN, Callier SL, Bentley AR, Stevens H, Phillips KA, Jansen JP, Weyant CF, Roberts DE, Zielinski D, Erlich Y, Garrison NA, Carroll SR, Ossorio PN, Moreau Y, Wang M. PMID: 33542123; PMCID: PMC8011351.
      View in: PubMed   Mentions: 5     Fields:    
    9. Aligning text mining and machine learning algorithms with best practices for study selection in systematic literature reviews. Syst Rev. 2020 Dec 13; 9(1):293. Popoff E, Besada M, Jansen JP, Cope S, Kanters S. PMID: 33308292; PMCID: PMC7734810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer. J Comp Eff Res. 2020 12; 9(18):1275-1284. Keeping ST, Cope S, Chan K, Wilson FR, Jansen JP, Penrod JR, Abraham P, Camidge DR, Korytowsky B, Gu T, Garcia AJ, Le TK, Yuan Y. PMID: 33140652.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis. J Manag Care Spec Pharm. 2020 Oct; 26(10):1236-1242. Incerti D, Hernandez EJM, Tkacz J, Jansen JP, Collier D, Gharaibeh M, Moore-Schiltz L, Stolshek BS. PMID: 32996384.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Response to Letter to Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma". Biol Blood Marrow Transplant. 2020 12; 26(12):e335-e336. Oluwole OO, Jansen JP, Lin VW, Chan K, Keeping S, Navale L, Locke FL. PMID: 32950694.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysis. BMJ Open. 2020 09 17; 10(9):e034147. Thom H, Jansen J, Shafrin J, Zhao L, Joseph G, Cheng HY, Gupta S, Shah N. PMID: 32948541; PMCID: PMC7500297.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. KRAS mutation as a prognostic factor and predictive factor in advanced/metastatic non-small cell lung cancer: A systematic literature review and meta-analysis. Cancer Treat Res Commun. 2020; 24:100200. Goulding RE, Chenoweth M, Carter GC, Boye ME, Sheffield KM, John WJ, Leusch MS, Muehlenbein CE, Li L, Jen MH, Rojubally A, Jansen J, Druyts E. PMID: 32750661.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma. Biol Blood Marrow Transplant. 2020 09; 26(9):1581-1588. Oluwole OO, Jansen JP, Lin VW, Chan K, Keeping S, Navale L, Locke FL. PMID: 32561336.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    16. Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis. Clin Kidney J. 2021 Apr; 14(4):1136-1146. Ortiz A, Kanters S, Hamed A, DasMahapatra P, Poggio E, Maski M, Aguiar M, Ponce E, Jansen JP, Ayers D, Goldgrub R, Desnick RJ. PMID: 33841859; PMCID: PMC8023189.
      View in: PubMed   Mentions: 2  
    17. Heterogeneity and subgroup analysis in network meta-analysis. In: Ting N, Cappelleri J, Ho S, Chen G. (editors). Design and analysis of subgroups with biopharmaceutical applications. Emerging topics in statistics and biostatistics. Springer, Cham. 2020; 369-385. Jansen JP.
    18. Multivariate network meta-analysis of survival function parameters. Res Synth Methods. 2020 May; 11(3):443-456. Cope S, Chan K, Jansen JP. PMID: 32125077.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma. Value Health. 2020 04; 23(4):441-450. Cope S, Toor K, Popoff E, Fonseca R, Landgren O, Mateos MV, Weisel K, Jansen JP. PMID: 32327161; PMCID: PMC7480667.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. The economic burden of kidney graft failure in the United States. Am J Transplant. 2020 05; 20(5):1323-1333. Sussell J, Silverstein AR, Goutam P, Incerti D, Kee R, Chen CX, Batty DS, Jansen JP, Kasiske BL. PMID: 32020739.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project. Pharmacoeconomics. 2019 11; 37(11):1313-1320. Jansen JP, Incerti D, Linthicum MT. PMID: 31392665; PMCID: PMC6860458.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    22. Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Gu�rin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8. Adv Ther. 2019 11; 36(11):2982-2985. Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Gu?rin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM. PMID: 31512141; PMCID: PMC6822794.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia. BMC Med Res Methodol. 2019 09 02; 19(1):182. Cope S, Ayers D, Zhang J, Batt K, Jansen JP. PMID: 31477025; PMCID: PMC6721254.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    24. Indirect comparison of nivolumab � ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer. J Comp Eff Res. 2019 07; 8(10):733-751. Cope S, Keeping ST, Goldgrub R, Ayers D, Jansen JP, Penrod JR, Korytowsky B, Juarez-Garcia A, Yuan Y. PMID: 31237143.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis. J Neurol. 2019 Sep; 266(9):2312-2321. Berger KI, Kanters S, Jansen JP, Stewart A, Sparks S, Haack KA, Bolzani A, Siliman G, Hamed A. PMID: 31187190; PMCID: PMC6687674.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework. Value Health. 2019 06; 22(6S):S12-S17. Garrison LP, Jansen JP, Devlin NJ, Griffin S. PMID: 31200801.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    27. A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis. Pharmacoeconomics. 2019 06; 37(6):829-843. Incerti D, Curtis JR, Shafrin J, Lakdawalla DN, Jansen JP. PMID: 30737711.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    28. Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System. J Manag Care Spec Pharm. 2019 May; 25(5):518-521. Jansen JP, Incerti D, Curtis JR. PMID: 31039069.
      View in: PubMed   Mentions: 2     Fields:    
    29. R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment. Value Health. 2019 05; 22(5):575-579. Incerti D, Thom H, Baio G, Jansen JP. PMID: 31104737.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    30. Incorporating single-arm evidence into a network meta-analysis using aggregate level matching: Assessing the impact. Stat Med. 2019 06 30; 38(14):2505-2523. Leahy J, Thom H, Jansen JP, Gray E, O'Leary A, White A, Walsh C. PMID: 30895655.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1. Adv Ther. 2019 05; 36(5):1164-1176. Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Gu?rin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM. PMID: 30879249; PMCID: PMC6824368.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    32. The number needed to treat and relevant between-trial comparisons of competing interventions. Clinicoecon Outcomes Res. 2018; 10:865-871. Jansen JP, Khalid JM, Smyth MD, Patel H. PMID: 30588048; PMCID: PMC6298880.
      View in: PubMed   Mentions: 2  
    33. Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Clin Res Cardiol. 2019 May; 108(5):487-509. Lorenzi M, Ambegaonkar B, Baxter CA, Jansen J, Zoratti MJ, Davies G. PMID: 30302558.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference? Health Policy. 2018 06; 122(6):607-613. Shafrin J, Skornicki M, Brauer M, Villeneuve J, Lees M, Hertel N, Penrod JR, Jansen J. PMID: 29731176.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes. PLoS One. 2018; 13(2):e0191953. Ericsson Å, Glah D, Lorenzi M, Jansen JP, Fridhammar A. PMID: 29408938; PMCID: PMC5800677.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. Network Meta‐Analysis for Decision Making. 2018. Dias S, Ades AE. Welton N, Jansen JP, Sutton A.
    37. An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin. J Med Econ. 2018 Apr; 21(4):340-347. Evans M, Billings LK, Håkan-Bloch J, Slothuus U, Abrahamsen TJ, Andersen A, Jansen JP. PMID: 29164973.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    38. Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators. J Med Econ. 2017 Jul; 20(7):703-714. Jansen JP, Incerti D, Mutebi A, Peneva D, MacEwan JP, Stolshek B, Kaur P, Gharaibeh M, Strand V. PMID: 28294642.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Relevance of American Society of Clinical Oncology Value Framework Will Be Improved if It Is Based on Network Meta-Analyses. J Clin Oncol. 2017 04 01; 35(10):1131-1132. Jansen JP. PMID: 28165901.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. J Med Econ. 2017 Jun; 20(6):555-564. Toth PP, Danese M, Villa G, Qian Y, Beaubrun A, Lira A, Jansen JP. PMID: 28097904.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    41. Treatment modifying factors of biologics for psoriatic arthritis: a systematic review and Bayesian meta-regression. Clin Exp Rheumatol. 2017 Jul-Aug; 35(4):681-688. Druyts E, Palmer JB, Balijepalli C, Chan K, Fazeli MS, Herrera V, Jansen JP, Park JJH, Kanters S, Reimold A. PMID: 28094756.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis. Diabetes Ther. 2017 Feb; 8(1):85-99. Lorenzi M, Ploug UJ, Langer J, Skovgaard R, Zoratti M, Jansen J. PMID: 27995594; PMCID: PMC5306116.
      View in: PubMed   Mentions: 7  
    43. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis. Clin Ther. 2016 Dec; 38(12):2628-2641.e5. Vieira MC, Zwillich SH, Jansen JP, Smiechowski B, Spurden D, Wallenstein GV. PMID: 27889300.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    44. Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016 08 18; 17(1):348. Jansen JP, Vieira MC, Bradley JD, Cappelleri JC, Zwillich SH, Wallenstein GV. PMID: 27538585; PMCID: PMC4991055.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol. 2017 Apr; 264(4):621-630. Schoser B, Stewart A, Kanters S, Hamed A, Jansen J, Chan K, Karamouzian M, Toscano A. PMID: 27372449.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    46. Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis. BMC Med Inform Decis Mak. 2015 Dec 02; 15:102. Broekhuizen H, Groothuis-Oudshoorn CG, Hauber AB, Jansen JP, IJzerman MJ. PMID: 26626279; PMCID: PMC4667469.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    47. Erratum to: A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly. Infect Dis Ther. 2015 Dec; 4(4):489-90. Mullikin M, Tan L, Jansen JP, Van Ranst M, Farkas N, Petri E. PMID: 26407566; PMCID: PMC4675764.
      View in: PubMed   Mentions:
    48. Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing. Curr Med Res Opin. 2015 Nov; 31(11):2031-42. Szabo SM, Hedegaard M, Chan K, Thorlund K, Christensen R, Vorum H, Jansen JP. PMID: 26296050.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly. Infect Dis Ther. 2015 Dec; 4(4):459-87. Mullikin M, Tan L, Jansen JP, Van Ranst M, Farkas N, Petri E. PMID: 26350238; PMCID: PMC4675767.
      View in: PubMed   Mentions: 7  
    50. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015 Jun 02; 162(11):777-84. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catal?-L?pez F, G?tzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. PMID: 26030634.
      View in: PubMed   Mentions: 1751     Fields:    Translation:Humans
    51. Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis. J Manag Care Spec Pharm. 2015 May; 21(5):409-23. Buckley F, Finckh A, Huizinga TW, Dejonckheere F, Jansen JP. PMID: 25943002.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    52. Network meta-analysis of longitudinal data using fractional polynomials. Stat Med. 2015 Jul 10; 34(15):2294-311. Jansen JP, Vieira MC, Cope S. PMID: 25877808.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis. J Med Econ. 2015 Jun; 18(6):437-46. Toor K, Druyts E, Jansen JP, Thorlund K. PMID: 25629655.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials. Value Health. 2015 Mar; 18(2):234-49. Cope S, Clemens A, Hamm?s F, Noack H, Jansen JP. PMID: 25773559.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    55. Heterogeneity in meta-analysis of FDG-PET studies to diagnose lung cancer. JAMA. 2015 Jan 27; 313(4):419. Mills EJ, Jansen JP, Kanters S. PMID: 25626041.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. Incorporating alternative design clinical trials in network meta-analyses. Clin Epidemiol. 2015; 7:29-35. Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ. PMID: 25565891; PMCID: PMC4278731.
      View in: PubMed   Mentions: 1  
    57. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014 Sep 03; 312(9):923-33. Johnston BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, Ball GD, Busse JW, Thorlund K, Guyatt G, Jansen JP, Mills EJ. PMID: 25182101.
      View in: PubMed   Mentions: 167     Fields:    Translation:Humans
    58. Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis. Health Qual Life Outcomes. 2014 Jul 03; 12:102. Jansen JP, Buckley F, Dejonckheere F, Ogale S. PMID: 24988902; PMCID: PMC4101713.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    59. A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer. BMC Med. 2014 Jun 05; 12:93. Cope S, Zhang J, Saletan S, Smiechowski B, Jansen JP, Schmid P. PMID: 24898705; PMCID: PMC4077675.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    60. Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis. Value Health. 2014 Jun; 17(4):424-32. Ellis AG, Reginster JY, Luo X, Cappelleri JC, Chines A, Sutradhar S, Jansen JP. PMID: 24969003; PMCID: PMC5583519.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women. Curr Med Res Opin. 2014 Aug; 30(8):1617-26. Ellis AG, Reginster JY, Luo X, Bushmakin AG, Williams R, Sutradhar S, Mirkin S, Jansen JP. PMID: 24773456.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    62. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health. 2014 Mar; 17(2):157-73. Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G. PMID: 24636374.
      View in: PubMed   Mentions: 109     Fields:    Translation:Humans
    63. Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making. BMC Med Res Methodol. 2013 Dec 01; 13:147. Cope S, Jansen JP. PMID: 24289277; PMCID: PMC3866977.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    64. Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis. Respir Res. 2013 Oct 07; 14:100. Cope S, Donohue JF, Jansen JP, Kraemer M, Capkun-Niggli G, Baldwin M, Buckley F, Ellis A, Jones P. PMID: 24093477; PMCID: PMC4014806.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    65. A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manage. 2014 Apr; 47(4):772-785.e5. Zeppetella G, Davies A, Eijgelshoven I, Jansen JP. PMID: 23981487.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    66. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med. 2013 Jul 04; 11:159. Jansen JP, Naci H. PMID: 23826681; PMCID: PMC3707819.
      View in: PubMed   Mentions: 181     Fields:    Translation:Humans
    67. Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models. Value Health. 2013 Mar-Apr; 16(2):403-17. Cope S, Ouwens MJ, Jansen JP, Schmid P. PMID: 23538193.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes. BMC Med Res Methodol. 2012 Oct 08; 12:152. Jansen JP, Cope S. PMID: 23043545; PMCID: PMC3570315.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    69. Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. Oncologist. 2012; 17(11):1376-85. Dequen P, Lorigan P, Jansen JP, van Baardewijk M, Ouwens MJ, Kotapati S. PMID: 23024154; PMCID: PMC3500357.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Efficacy of indacaterol 75 �g versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis. Int J Chron Obstruct Pulmon Dis. 2012; 7:415-20. Cope S, Kraemer M, Zhang J, Capkun-Niggli G, Jansen JP. PMID: 22848154; PMCID: PMC3402062.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. Efficacy of once-daily indacaterol 75 �g relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis. BMC Pulm Med. 2012 Jun 25; 12:29. Cope S, Zhang J, Williams J, Jansen JP. PMID: 22732017; PMCID: PMC3512498.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    72. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis. J Cyst Fibros. 2012 Sep; 11(5):419-26. Littlewood KJ, Higashi K, Jansen JP, Capkun-Niggli G, Balp MM, Doering G, Tiddens HA, Angyalosi G. PMID: 22717535.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    73. Economic outcomes of treatment for ureteral and renal stones: a systematic literature review. J Urol. 2012 Aug; 188(2):449-54. Matlaga BR, Jansen JP, Meckley LM, Byrne TW, Lingeman JE. PMID: 22698623; PMCID: PMC3787850.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    74. Accounting for correlation in network meta-analysis with multi-arm trials. Res Synth Methods. 2012 Jun; 3(2):142-60. Franchini AJ, Dias S, Ades AE, Jansen JP, Welton NJ. PMID: 26062087.
      View in: PubMed   Mentions: 28     Fields:    
    75. Network meta-analysis of individual and aggregate level data. Res Synth Methods. 2012 Jun; 3(2):177-90. Jansen JP. PMID: 26062089.
      View in: PubMed   Mentions: 36     Fields:    
    76. Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials. J Urol. 2012 Jul; 188(1):130-7. Matlaga BR, Jansen JP, Meckley LM, Byrne TW, Lingeman JE. PMID: 22591962; PMCID: PMC3774029.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    77. Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons. J Clin Epidemiol. 2012 Jul; 65(7):798-807. Jansen JP, Schmid CH, Salanti G. PMID: 22521579.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    78. Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison. Value Health. 2012 May; 15(3):524-33. Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP. PMID: 22583463.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. Efficacy of etoricoxib, celecoxib, lumiracoxib, non-selective NSAIDs, and acetaminophen in osteoarthritis: a mixed treatment comparison. Open Rheumatol J. 2012; 6:6-20. Stam W, Jansen J, Taylor S. PMID: 22582102; PMCID: PMC3349945.
      View in: PubMed   Mentions: 8  
    80. Epidemiology of HIV-related neuropathy: a systematic literature review. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):36-48. Ghosh S, Chandran A, Jansen JP. PMID: 21902585.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    81. Comparative effectiveness of efavirenz, protease inhibitors, and raltegravir-based regimens as first-line treatment for HIV-infected adults: a mixed treatment comparison. HIV Clin Trials. 2011 Jul-Aug; 12(4):175-89. Vieira MC, Kumar RN, Jansen JP. PMID: 22044854.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    82. Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway. Int J Rheumatol. 2011; 2011:160326. Jansen JP, Taylor SD. PMID: 21772851; PMCID: PMC3134091.
      View in: PubMed   Mentions: 3  
    83. Comparative efficacy of indacaterol 150 �g and 300 �g versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis. Int J Chron Obstruct Pulmon Dis. 2011; 6:329-44. Cope S, Capkun-Niggli G, Gale R, Jardim JR, Jansen JP. PMID: 21697997; PMCID: PMC3119108.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    84. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health. 2011 Jun; 14(4):429-37. Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A. PMID: 21669367.
      View in: PubMed   Mentions: 208     Fields:    Translation:Humans
    85. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011 Jun; 14(4):417-28. Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. PMID: 21669366.
      View in: PubMed   Mentions: 296     Fields:    Translation:Humans
    86. Network meta-analysis of survival data with fractional polynomials. BMC Med Res Methodol. 2011 May 06; 11:61. Jansen JP. PMID: 21548941; PMCID: PMC3112194.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    87. Network meta-analysis of parametric survival curves. Res Synth Methods. 2010 Jul; 1(3-4):258-71. Ouwens MJ, Philips Z, Jansen JP. PMID: 26061470.
      View in: PubMed   Mentions: 34     Fields:    
    88. An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer. Value Health. 2011 Mar-Apr; 14(2):274-81. Vissers DC, Lenre M, Tolley K, Jakobsson J, Sendersky V, Jansen JP. PMID: 21402296.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    89. Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden. Scand J Infect Dis. 2011 Jul; 43(6-7):504-14. Naik S, Lundberg J, Kumar R, Sjolin J, Jansen JP. PMID: 21332286.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. Curr Med Res Opin. 2011 Jan; 27(1):225-38. van de Kerkhof P, de Peuter R, Ryttov J, Jansen JP. PMID: 21142833.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    91. The critical role of observational evidence in comparative effectiveness research. Health Aff (Millwood). 2010 Oct; 29(10):1826-33. Fleurence RL, Naci H, Jansen JP. PMID: 20921482.
      View in: PubMed   Mentions: 12     Fields:    
    92. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis. Semin Arthritis Rheum. 2011 Feb; 40(4):275-84.e1-2. Jansen JP, Bergman GJ, Huels J, Olson M. PMID: 20828791.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    93. Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands. Ann Hematol. 2010 Sep; 89(9):919-26. Jansen JP, O'Sullivan AK, Lugtenburg E, Span LF, Janssen JJ, Stam WB. PMID: 20383504; PMCID: PMC2908442.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    94. Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum. 2010 Jun; 39(6):425-41. Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP. PMID: 20223500.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    95. Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitis. Pharmacoeconomics. 2010; 28(4):323-44. Jansen JP, Gaugris S, Choy EH, Ostor A, Nash JT, Stam W. PMID: 20222755.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer. Curr Med Res Opin. 2010; 5(26):1037-45. Vissers DCJ, Nolte T, Stam WB, Lenre M, Jansen J. .
    97. Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck. Head Neck. 2009 Oct; 31(10):1255-62. Parthan A, Posner MR, Brammer C, Beltran P, Jansen JP. PMID: 19731394.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    98. Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies. Curr Med Res Opin. 2009 Aug; 25(8):1861-8. Jansen JP, Bergman GJ, Huels J, Olson M. PMID: 19530978.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    99. Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance. Value Health. 2009 Mar-Apr; 12(2):234-44. Jansen JP, Kumar R, Carmeli Y. PMID: 20667059.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    100. Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. Pharmacoeconomics. 2009; 27(12):1045-56. Jansen JP, Kumar R, Carmeli Y. PMID: 19908928.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    101. Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands. Eur J Haematol. 2008 Dec; 81(6):467-74. Stam WB, O'Sullivan AK, Rijnders B, Lugtenburg E, Span LF, Janssen JJ, Jansen JP. PMID: 18754857.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    102. Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy. Value Health. 2008 Sep-Oct; 11(5):830-41. Stam WB, Aversa F, Kumar RN, Jansen JP. PMID: 18494752.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    103. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008 Sep-Oct; 11(5):956-64. Jansen JP, Crawford B, Bergman G, Stam W. PMID: 18489499.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    104. Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands. Curr Med Res Opin. 2008 Mar; 24(3):671-84. Jansen JP, Gaugris S, Bergman G, Sen SS. PMID: 18221588.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    105. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK. Curr Med Res Opin. 2007 Dec; 23(12):3069-78. Jansen JP, Pellissier J, Choy EH, Ostor A, Nash JT, Bacon P, Hunsche E. PMID: 17971283.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    106. A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Eur J Haematol. 2007 Jun; 78(6):532-9. Bruynesteyn K, Gant V, McKenzie C, Pagliuca T, Poynton C, Kumar RN, Jansen JP. PMID: 17419744; PMCID: PMC1974808.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    107. Predicting the long term course of low back pain and its consequences for sickness absence and associated work disability. Occup Environ Med. 2006 Aug; 63(8):522-9. Burdorf A, Jansen JP. PMID: 16849528; PMCID: PMC2078120.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    108. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin. 2006 Apr; 22(4):671-81. Jansen JP. PMID: 16684428.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    109. Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany. Value Health. 2006 Jan-Feb; 9(1):12-23. Jansen JP, Kern WV, Cornely OA, Karthaus M, Ruhnke M, Ullmann AJ, Resch A. PMID: 16441520.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    110. The relations between psychosocial factors at work and health status among workers in home care organizations. Int J Behav Med. 2006; 13(3):183-92. Eriksen HR, Ihlebaek C, Jansen JP, Burdorf A. PMID: 17078768.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    111. Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands. Curr Med Res Opin. 2005 Oct; 21(10):1535-46. Jansen JP, Meis JF, Blijlevens NM, van't Wout JW. PMID: 16238893.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    112. Dose-response relations between occupational exposures to physical and psychosocial factors and the risk of low back pain. Occup Environ Med. 2004 Dec; 61(12):972-9. Jansen JP, Morgenstern H, Burdorf A. PMID: 15550602; PMCID: PMC1740687.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansPHPublic Health
    113. Effects of measurement strategy and statistical analysis on dose-response relations between physical workload and low back pain. Occup Environ Med. 2003 Dec; 60(12):942-7. Jansen JP, Burdorf A. PMID: 14634186; PMCID: PMC1740438.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    114. Exposure assessment and its effect on the associations of physical load and back disorders. Arch Public Health. 2002; (60):153-72. Jansen JP, Burdorf A.
    115. A novel approach for evaluating level, frequency and duration of lumbar posture simultaneously during work. Scand J Work Environ Health. 2001 Dec; 27(6):373-80. Jansen JP, Burdorf A, Steyerberg E. PMID: 11800324.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    Jeroen's Networks
    Concepts (409)
    Derived automatically from this person's publications.
    Co-Authors (1)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department